AGL 38.50 Increased By ▲ 0.93 (2.48%)
AIRLINK 131.50 Decreased By ▼ -1.00 (-0.75%)
BOP 5.63 Decreased By ▼ -0.01 (-0.18%)
CNERGY 3.84 Increased By ▲ 0.07 (1.86%)
DCL 8.65 Decreased By ▼ -0.22 (-2.48%)
DFML 40.75 Decreased By ▼ -0.25 (-0.61%)
DGKC 89.10 Decreased By ▼ -1.06 (-1.18%)
FCCL 35.25 Increased By ▲ 0.17 (0.48%)
FFBL 66.48 Decreased By ▼ -0.02 (-0.03%)
FFL 10.44 Increased By ▲ 0.29 (2.86%)
HUBC 109.55 Increased By ▲ 3.15 (2.96%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.83 Decreased By ▼ -0.03 (-0.62%)
KOSM 7.07 Increased By ▲ 0.22 (3.21%)
MLCF 42.45 Increased By ▲ 0.65 (1.56%)
NBP 59.06 Increased By ▲ 0.48 (0.82%)
OGDC 183.77 Increased By ▲ 2.52 (1.39%)
PAEL 25.55 Decreased By ▼ -0.15 (-0.58%)
PIBTL 5.92 Increased By ▲ 0.09 (1.54%)
PPL 147.79 Decreased By ▼ -0.61 (-0.41%)
PRL 23.54 Increased By ▲ 0.32 (1.38%)
PTC 16.55 Increased By ▲ 1.31 (8.6%)
SEARL 69.49 Increased By ▲ 0.70 (1.02%)
TELE 7.25 Increased By ▲ 0.01 (0.14%)
TOMCL 35.75 Decreased By ▼ -0.25 (-0.69%)
TPLP 7.51 Increased By ▲ 0.11 (1.49%)
TREET 14.11 Decreased By ▼ -0.13 (-0.91%)
TRG 50.71 Decreased By ▼ -0.14 (-0.28%)
UNITY 26.87 Increased By ▲ 0.47 (1.78%)
WTL 1.23 Increased By ▲ 0.02 (1.65%)
BR100 9,808 Increased By 40.5 (0.41%)
BR30 29,764 Increased By 364.3 (1.24%)
KSE100 92,330 Increased By 392.4 (0.43%)
KSE30 28,828 Increased By 84.5 (0.29%)
Pakistan

DRAP permits clinical trials of plasma therapy for Coronavirus treatment: Zafar Mirza

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ve
Published April 9, 2020
  • The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.
  • More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.
  • The companies will prepare quality sanitizers as per the directions of the World Health Organization.

ISLAMABAD: Special Assistant to the Prime Minister on National Health Services, Dr. Zafar Mirza Thursday announced that Drug Regulatory Authority of Pakistan (DRAP) has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.

In a statement, he said the DRAP has also permitted clinical trials of plasma therapy for coronavirus treatment, Electronic/Radio channel reported.

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.

More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.

The companies will prepare quality sanitizers as per the directions of the World Health Organization.

Comments

Comments are closed.